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Purpose: Carbon monoxide (CO) may mediate smooth muscle relaxation in the rat cor-
pus cavernosum smooth muscle (CCSM). We hypothesized that CO plays a role in neu-
rally derived, frequency-dependent relaxation of rat CCSM.
Materials and Methods: To study the effect of CO on CCSM relaxation induced by elec-
trical field stimulation (EFS), a CCSM bundle was mounted on a force transducer and 
perfused with Hanks’ balanced salt solution at 37
oC with 95% O2 and 5% CO2. After 
1 hour equilibration with -500 mg of passive tension, contraction of the CCSM bundle 
was elicited by 10
−5 M phenylephrine, which was continuously added with different 
concentrations of CO (1%, 2%, and 5%). Frequency-dependent relaxation was induced 
by EFS trains (0.2 ms at 0.5-32 Hz, for 10 s) repeated at 2 min intervals over 15 min 
in the presence of adrenergic and muscarinic receptor blocking agents (guanethidine 
and atropine, respectively). To study the distribution of heme oxygenase-2 (HO-2) in 
the rat CCSM, we performed immunohistochemical evaluation.
Results:  CO produced a dose-dependent enhancement of EFS-induced relaxation. 
Pretreatment with N
G-nitro-L-arginine (a nitric oxide synthase blocker) greatly re-
duced the EFS-induced relaxation in the presence of CO (-45%). Pretreatment with zinc 
protoporphyrin-IX (ZnPP-9, a heme oxygenase inhibitor) had no significant effect on 
EFS-induced relaxation in the absence or the presence of CO. We found immunor-
eactivity for HO-2 in CCSM and immunoreactivity for protein gene product 9.5 (PGP 
9.5) in nerve fibers.
Conclusions: We conclude that CO produced a dose-dependent enhancement of EFS-in-
duced relaxation in rat CCSM bundles, but neurally derived, frequency-dependent re-
laxation in the rat CCSM depended mostly on nitric oxide in response to nonadrenergic 
noncholinergic neurotransmission. Immunoreactivity for HO-2 was found in rat CCSM 
but not nerve fibers.
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INTRODUCTION
Relaxation of cavernosal smooth muscle and artery is im-
portant in the process of penile erection. Previous studies 
indicated that nitric oxide (NO) is a physiological mes-
senger molecule/neurotransmitter that mediates the regu-
lation of corpus cavernosum smooth muscle (CCSM) func-
tion and arterial tone by the activation of soluble guanylate 
cyclase (SGC) with binding to the heme moiety of that en-
zyme [1,2]. NO is known to be produced in the nerves, endo-
thelium, and muscle by nitric oxide synthase (NOS) [3,4]. 
The enzyme NOS has close homology to cytochrome P-450 
reductase, the source of electrons for heme oxygenase 
(HO)-mediated production of carbon monoxide (CO), acti-Korean J Urol 2010;51:572-578
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vating guanylate cyclase by binding to the heme moiety 
[5,6].
　It has been proposed that CO might act in a fashion sim-
ilar to that of NO [7]. CO is a noxious gas that can bind to 
the iron atom of hemoproteins and that also activates SGC, 
leading to an increase in endogenous cyclic guanosine 
3',5'-monophosphate (cGMP) levels and consequent relax-
ation of smooth muscle [8,9]. Like NO, exogenously applied 
CO has been shown to cause relaxation of various isolated 
blood vessels by increasing endogenous cGMP levels and 
has also been claimed as a novel neuroendocrine modulator 
for the regulation of vascular smooth muscle tone [9]. The 
penis is a vascular organ, and therefore, CO may have roles 
in the tumescence or detumescence of the corpus cav-
ernosum in conjunction with NO. However, previous stud-
ies on rabbit CCSM and rabbit cerebral arteries indicated 
that endogenous CO had no significant effect on relaxation 
or tone [10,11]. 
　Penile erection following relaxation of CCSM is known 
to be primarily mediated by NO produced in response to 
nonadrenergic noncholinergic (NANC) neurotransmis-
sion [11,12]. NO also mediates a significant component of 
NANC neurotransmission in intestinal smooth muscle 
[13]. CO is required for NO-mediated intestinal NANC 
neurotransmission [13]. In addition, the suppression of 
NANC-mediated relaxation by the HO inhibitor (zinc pro-
toporphyrin-IX; ZnPP-9) was reported to imply the involve-
ment of CO in neurally mediated sphincteric smooth mus-
cle relaxation [14]. In the presence of adrenergic and mus-
carinic receptor blocking agents (guanethidine and atro-
pine, respectively), electrical field stimulation (EFS) ex-
cites only the NANC nerves, which leads to rapid and tran-
sient relaxation in pre-contracted CCSM [12]. The purpose 
of this study was to examine the hypothesis that CO plays 
a role in neurally derived, frequency-dependent relaxation 
of rat CCSM in response to NANC neurotransmission.
MATERIALS AND METHODS
1. Tissue preparation
Male Sprague-Dawley rats (-300 g) were used in the pres-
ent study. Animals were anesthetized with ketamine (60 
mg/kg) and xylazine (2.5 mg/kg). Corporal biopsy samples 
were obtained from 15 rats (5 for immunohistochemistry 
and 10 for isometric force measurement). All procedures 
were approved by the Institutional Animal Care and Use 
Committee of the Chonbuk National University.
2. Materials and solutions
Custom-made gas mixtures with different concentrations 
of CO (1%, 2%, 5%) were obtained from Praxair, Inc. (St. 
Louis, MO, USA). Zamboni’s fixative (2% paraformalde-
hyde, 0.2% picric acid in 0.1 M phosphate buffer, pH 7.4) 
was obtained from Newcomer (Middleton, WI, USA). 
Triton-X-100, phenylephrine, N
G-nitro-L-arginine (L- 
NOARG), guanethidine, atropine, and ZnPP-9 were ob-
tained from Sigma (St. Louis, MO, USA). Ornithine carba-
moyltransferase (OCT) compound was obtained from 
Tissue-Tek, Sakura, Finetek Inc. (CA, USA). Normal don-
key serum (NDS) was obtained from Jackson, Immuno-
Research Laboratory (West Grove, PA, USA). Antibody 
raised in rabbit to HO-2 was obtained from StressGen 
Biotechnology (Victoria, BC, Canada). Antibody raised in 
mouse to protein gene product 9.5 (PGP 9.5) was obtained 
from Biogenesis (Sandown, NH, USA). CY 
TM3-conjugated 
AffiniPure donkey anti-rabbit IgG and CY 
TM2-conjugated 
AffiniPure donkey anti-mouse IgG were obtained from 
Jackson, ImmunoResearch Laboratory (West Grove, PA, 
USA). 10x Hank’s balanced salt solution (HBSS) was ob-
tained from Invitrogen Corporation (Grand Island, NY, 
USA). 
3. Drug preparation
ZnPP-9 (0.1 mM) was dissolved in a small volume of 0.1 N 
NaOH solution, diluted in HBSS, and titrated to pH 7.4 
with 0.1 N HCl. Other substances were dissolved in HBSS 
solution.
4. Immunohistochemistry
All specimens were immediately immersed in Zamboni's 
fixative (2% paraformaldehyde, 0.2% picric acid in 0.1 M 
phosphate buffer, pH 7.4, Newcomer Supply, Middleton, 
WI, USA) for 4  hour at 4
oC, followed by several washes in 
cold phosphate-buffered saline (PBS) solution. Prior to sec-
tioning, all tissues were stored at 4
oC in PBS containing 
30% sucrose solution and 0.01% sodium azide (Sigma 
Chemicals Co., St. Louis, MO, USA) for at least 24 hour. 
All sections were immediately processed by immersion in 
OCT compound (Tissue-Tek, Sakura, Finetek Inc., CA, 
USA) before snap-freezing in −60
oC viscous isopentane 
(Sigma Chemicals Co., St. Louis, MO, USA) cooled with a 
dry ice slurry. The frozen samples were then stored at −70
oC 
for subsequent immunohistochemical evaluation. 
　Cryostat sections, 20 μm thick, were mounted on slides 
coated with gelatin and chrome alum. Slides were rinsed 
3 times with 0.1 M PBS solution for 30 min. All slides were 
subsequently incubated in PBS solution containing 0.3% 
(v/v) Triton-X 100 (Sigma Chemical Co., St. Louis, MO, 
USA) and 10% (v/v) NDS (Jackson, ImmunoResearch 
Laboratories, Inc., West Grove, PA, USA) for 120 min at 
room temperature in a humid chamber. Slides were in-
cubated overnight with antiserum raised in rabbits to 
HO-2 (1:500 diluted in 0.1 M PBS solution containing 5% 
NDS, 0.3% Triton-X 100; StressGen Biotechnologies, 
Corp., Victoria, British Columbia, Canada) and antiserum 
raised in mouse to PGP 9.5 (1:1,600 diluted in 0.1 M PBS 
containing 5% NDS, 0.3% Triton-X 100; Biogenesis, 
Sandown, NH, USA) in a humid chamber at room tem-
perature. Unbound primary antibodies were washed from 
the sections with 0.1 M PBS solution 3 times for 10 min. 
After this washout, the sections were exposed for 2 hour at 
room temperature to CY 
TM3-conjugated AffiniPure donkey 
anti-rabbit IgG (1:100 diluted in 0.1M PBS containing 5% 
NDS, 0.3% Triton-X 100; Jackson, ImmunoResearch Labo-Korean J Urol 2010;51:572-578
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FIG. 1. Immunohistochemical staining with antiserum raised in
rabbit to heme oxygenase-2 in rat penile smooth muscle. (A) 
Negative staining with rabbit serum (primary antibody) and sec-
ondary antibody (CY
TM3-conjugated AffiniPure donkey anti- rab-
bit IgG) (Control). (B) Positive staining with primary antibody 
(antiserum raised in rabbits to heme oxygenase-2) and secon-
dary antibody (CY
TM3-conjugated AffiniPure donkey anti- rabbit
IgG). (C) Nerve fibers stained with primary antibody (antiserum 
raised in mouse to protein gene product 9.5) and secondary anti-
body (CY
TM2-conjugated AffiniPure donkey anti- mouse IgG). (D) 
A composite of B and C. 
ratories, Inc., West Grove, PA, USA) for HO-2 and CY
TM2- 
conjugated AffiniPure donkey anti-mouse IgG (1:200 di-
luted in 0.1 M PBS solution containing 5% NDS, 0.3% 
Triton-X 100; Jackson, ImmunoResearch Laboratories, 
Inc., West Grove, PA, USA) for PGP 9.5. Following this sec-
ondary antiserum incubation, all sections were rinsed 3 
times for 10 min with 0.1 M PBS solution. The specimens 
were air-dried and cover-slipped by using xylene and were 
viewed with a Zeiss Axiophoto fluorescence microscope 
equipped with epi-illumination. To obtain CY
TM3-fluores-
cence and CY
TM2-fluorescence, excitation wavelengths of 
568 nm and 488 nm were used, respectively. Photographs 
of these fluorescent signals were taken at a magnification 
of x400 with Kodak (400 ASA) film. 
5. Isometric force measurements
A thin bundle of rat CCSM (2-3 mm long and -300 μm wide) 
was dissected under a dissecting microscope and mounted 
on a force transducer. The bundle, surrounded by the 
quartz cuvette (90 μl), was constantly perfused with HBSS 
buffered with 10 mM N-[2-Hydroxyethyl]piperazine-N’[2- 
ethanesulfonic] acid (pH 7.4) aerated with 95% O2 and 5% 
CO2 at 37
oC. After 1 hour equilibration with -500 mg of pas-
sive tension, contraction of the CCSM bundle was elicited 
by 10 μM phenylephrine (Phe; Sigma Chemical Co., St. 
Louis, MO, USA). Force output signal was digitized at 10 
samples per s and displayed on a computer monitor by use 
of LabVIEW software (LabVIEW 5.0, Graphical Progra-
mming for Instrumentation).
6. Measurements of CO effect on CCSM relaxation induced 
by EFS
Frequency-dependent relaxation in Phe-precontracted 
bundles was induced by EFS trains (0.2 ms pulse duration 
at 0.5-32 Hz, for 10 s; Grass Stimulator, S88) repeated at 
2-min intervals over 15 min. The experiments were per-
formed in the presence of adrenergic and muscarinic re-
ceptor blocking agents (10 μM guanethidine and 1 μM atro-
pine, respectively). Following the control measurement in 
the absence of CO, the Phe-precontracted bundle was 
washed out with HBSS until it relaxed to the resting state. 
The resting fiber bundle inside the quartz cuvette was 
again precontracted by perfusing Phe solution, to which 
different concentrations of CO mixtures (1%, 2%, and 5%; 
Filling Method: Gravimetric; Praxair, Inc.) were con-
tinuously added during the plateau phase, respectively.
7. Measurements of effects of inhibitors on CCSM relaxa-
tion induced by EFS
Effects of inhibitors on EFS-induced relaxation from the 
Phe-induced contraction was measured in the presence of 
CO. Before the Phe-induced contraction, the fiber bundle 
was incubated for 1 hour with ZnPP-9 (0.1 mM) and L- 
NOARG (100 μM; NOS inhibitor), respectively.
8. Analysis of data
The in vitro isometric force response of CCSM to Phe varied 
across preparations. Therefore, relaxation effects were re-
ported as % of initial Phe-induced force response for each 
preparation. The normalized data were expressed as the 
mean±standard error (SE). Statistical comparisons were 
performed by using Student’s t-test for paired comparisons. 
Multiple comparisons were made with an analysis of vari-
ance (ANOVA). Differences were considered significant 
when p＜0.05. 
RESULTS
1. Distribution of HO-2 and PGP 9.5 immunoreactivity
The preparations in which non-immune normal rabbit se-
rum at a dilution of 1:500 was used instead of the primary 
antibody served as negative control (Fig. 1A). Immuno-
reactivity for HO-2 was observed throughout the CCSM 
(Fig. 1B), and immunoreactivity for PGP 9.5 was detected 
in nerve fibers (Fig. 1C) but not specifically in relation to 
the CCSM detected by HO-2 immunoreactivity (Fig. 1D).
2. CO effect on CCSM relaxation induced by EFS
Before application of EFS to Phe-precontracted CCSM, on-
ly the highest concentration of CO (5%) caused -12% relaxa-
tion in Phe-precontracted CCSM. However, this relaxant Korean J Urol 2010;51:572-578
Direct Effect of CO on Relaxation in CCSM 575
FIG. 4. Frequency-dependent relaxation of phenylephrine-pre-
contracted rat corpus cavernosum smooth muscle on different 
carbon monoxide concentrations (1%, 2%, and 5%). CTL: control,
CO: carbon monoxide.
FIG. 5. Effect of nitric oxide synthase inhibitor, N
G-nitro-L- 
arginine, on rat corpus cavernosum smooth muscle relaxation 
induced by electrical field stimulation in the presence of carbon
monoxide (5%). CO: carbon monoxide, HBSS: Hank’s balanced 
salt solution, L-NOARG: N
G-nitro-L-arginine, EFS: electrical 
field stimulation.
FIG. 2. Effect of different carbon monoxide (CO) concentrations 
(1%, 2%, and 5%) on relaxation in Phe-precontracted corpus 
cavernosum smooth muscle before exposure to electrical field 
stimulation. HBSS: Hank’s balanced salt solution.
FIG. 3. Effect of carbon monoxide (5%) on corpus cavernosum smooth
muscle (CCSM) relaxation induced by electrical field stimulation
(EFS). Rat CCSM was phenylephrine-precontracted and respon-
ded to EFS (0.5 to 32 Hz, 0.2 ms duration). HBSS: Hank’s balanced
salt solution.
effect was reversed in the absence of CO (Fig. 2). Fig. 3 
shows the effect of 5% CO on the CCSM relaxation induced 
by EFS. CO produced a dose-dependent enhancement of 
EFS-induced relaxation. While the frequency of EFS in-
creased from 0.5 Hz to 2.0 Hz, the effect of different CO con-
centrations (1%, 2%, and 5%) on CCSM relaxation was 
dose-dependently enhanced (12%, 15%, and 34% compared 
to control, respectively). During these low ranges of fre-
quencies, there were statistically significant differences in 
the relaxation of CCSM among the three groups of different 
CO concentrations (p＜0.05). During high ranges of fre-
quencies (above 2.0 Hz), however, CCSM relaxation in-
duced by EFS was maintained at a similar degree to relaxa-
tion demonstrated by 2.0 Hz (10%, 16%, and 32% compared 
to control, respectively), and there were also significant dif-
ferences in the relaxation of CCSM among the three groups 
(p＜0.05) (Fig. 4).
3. Effects of inhibitors on CCSM relaxation induced by EFS
Fig. 5 shows the effect of L-NOARG (an NOS inhibitor) on 
rat CCSM relaxation induced by EFS in the presence of CO 
(5%). Pretreatment with L-NOARG greatly reduced the 
EFS-induced relaxation in the presence of CO (-45% when 
compared to control) (p＜0.05), but ZnPP-9 had no sig-Korean J Urol 2010;51:572-578
576 Kim et al
FIG. 6. Inhibition of electrical field stimulation-induced relaxa-
tion of rat corpus cavernosum smooth muscle by antagonists 
(N
G-nitro-L-arginine, zinc protoporphyrin-IX) in the presence of
carbon monoxide (5%). CTL: control, CO: carbon monoxide, 
L-NOARG: N
G-nitro-L-arginine, ZnPP: zinc protoporphyrin.
nificant effect on EFS-induced relaxation (p＞0.05) (Fig. 6).
DISCUSSION
CO is a low molecular weight oxide that is endogenously 
produced from fatty acids and heme. CO is mainly produced 
by microsomal HO and activates SGC, leading to an in-
crease in cGMP levels and consequent relaxation of the 
smooth muscle [8,12]. There are two main isoforms of HO, 
HO-1 (inducible) and HO-2 (constitutive) [1,5], leading to 
the formation of biliverdin and CO and the release of iron. 
In addition, a third isoform of HO, HO-3, has been reported 
to have strong homology to HO-2, but little is known about 
its function [15]. HO-1 is inducible and is concentrated in 
organs in which erythrocyte hemoglobin degradation by 
mononuclear phagocytic cells normally takes place [16]. 
HO-2 is constitutively expressed in various rat tissues [16]. 
The levels of HO prevail from low to moderate in thymus, 
adrenal gland, kidney, lung, and heart [5]. 
　The present study demonstrated HO-2 immunoreac-
tivity in rat CCSM (Fig. 1B). However, HO-2 immunor-
eactivity was not specifically localized to nerve fibers in 
CCSM. Although exposure to exogenous CO (1%, 2%, and 
5%) produced a dose-dependent enhancement of EFS-in-
duced transient relaxation in Phe-precontracted CCSM 
(Fig. 5), the effect of endogenously released CO via nerve 
stimulation on EFS-induced relaxation was not observed 
in this study (Fig. 6). CO released by nerve terminals on 
EFS does not seem to have an important role in relaxation 
of CCSM. This result was supported by the fact that ex-
posure to a solution containing ZnPP-9 did not show sig-
nificant inhibition of EFS-induced relaxation (Fig. 6). 
However, CO has been reported to potentiate EFS-induced 
NO release by modulating NO production [17,18]. In addi-
tion, exogenous CO-induced relaxation in Phe pre-con-
tracted CCSM before exposure to EFS was observed (Fig. 
2). This relaxation may be mediated by CO-dependent acti-
vation of SGC and subsequent elevation of cGMP or CO-de-
pendent induction of NO release [18,19].
　Furchgott and Jothianandan reported that CO was less 
potent than NO as a relaxant in rabbit aorta (1:1,000) [9]. 
It was also reported that CO does not seem to have sig-
nificant effects on tone in cerebral arteries compared to NO 
[10]. Although CO may function like NO in terms of its abil-
ity to relax rat CCSM by stimulating SGC, the effect of CO 
as an endogenous neurotransmitter for relaxation could 
not be demonstrated in the rat CCSM. CO may function as 
an endogenous smooth muscle dilator when its concen-
tration is sufficiently high or when endogenous production 
of NO is relatively low [20].
　As with NO, CO is produced endogenously from NADPH- 
dependent enzymatic peroxidation of microsomal lipids 
and from NADPH-dependent oxidative heme destruction 
catalyzed by HO [14]. CO is also predominantly derived 
from the breakdown of heme and functions as another ga-
seous signaling molecule to stimulate SGC [1]. In other 
smooth muscles, CO has been demonstrated to be a neural 
messenger, important in regulating smooth muscle tone 
via alterations in endogenous cGMP levels [14,21]. However, 
unlike NO, CO was reported to have a cGMP-independent 
pathway. By activating the mitogen-activated protein kin-
ase (MAPK) pathway, CO has cytoprotective effects such 
as anti-inflammation and anti-apoptosis. The MAPK path-
way is involved in proliferation, apoptosis, and cytokine re-
lease [19]. Both CO and NO directly modify the function of 
other proteins, but when acting on the same protein, they 
may have different sites of action: calcium- activated large 
conductance potassium channels. NO increases the activ-
ity of calcium-dependent potassium channels via mod-
ifications to sulfhydryl groups, whereas CO modulates the 
activity of the same channels by modification of histidine 
residues. The effects of NO are mediated on the β subunit 
of the potassium channel, whereas those of CO are on the 
α subunit, again indicating the divergent mechanisms of 
action of NO and CO [22].
　It is generally accepted that NO is an essential mes-
senger for penile erection [23]. NO is normally produced by 
organs and serves as an important chemical messenger not 
only in the regulation of vascular tone, but also in neural 
transmission. NO-independent relaxation of certain blood 
vessels has been attributed to an endothelium-derived re-
laxing factor that hyperpolarizes vascular smooth muscle, 
which is referred to as endothelium-derived hyperpolarizing 
factor (EDHF) [24]. CO may be considered to work like 
EDHF. Ewing et al reported that HO-2 exists in endothelial 
cells of the descending aorta, and Zakhary et al discovered 
that HO-2 immunoreactivity was present in cultured bo-
vine aortic endothelial cells [20,25]. 
　NOS has been shown to be a cytochrome p-450 like hemo-
protein, containing a bound protoporphyrin IX. This may 
provide a mechanism for feedback regulation of the enzyme 
by NO or CO. The NO receptor, SGC, is also a hemoprotein Korean J Urol 2010;51:572-578
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[26]. It is highly likely that neurons containing guanylyl cy-
clase or NOS might bring about high levels of HO to allow 
modulation of these enzymes with CO or to regulate intra-
cellular heme levels [27]. The presence of HO-2 immunor-
eactivity in CCSM suggests that CO may play a role as a 
biological messenger molecule analogous to NO, albeit not 
through a neurally mediated release. In the normal vascu-
lature, the basal production of CO may be lower than that 
of NO. 
　As we previously stated, CO is a less potent vasodilator 
than NO and may not be the predominant regulator of ves-
sel integrity under basal conditions. However, during con-
ditions of vascular injury such as those caused by hypoxia, 
NO induction of HO stimulates the release of CO, thereby 
increasing levels of guanylate cyclase, which may offer a 
means of maintaining blood flow to damaged areas of vas-
culature [28]. The differential distribution of NOS and HO 
also suggests that NO may compete with CO in spinal cord 
neurons [29]. Endogenously produced CO may shut down 
electron flow through the enzyme by binding to the heme 
group of NOS, leading to further suppression of NOS and 
NO formation such as negative feedback control [30]. 
Because we used normal rats in the present study, it was 
not possible to study the pathophysiological roles of CO in 
rat CCSM.
CONCLUSIONS
CO produced a dose-dependent enhancement of EFS-induced 
relaxation in rat CCSM, but neurally derived, frequency- 
dependent relaxation in the rat CCSM depended mostly on 
NO. However, it is possible that CO can act as a partial ago-
nist to facilitate NO-mediated activation of SGC. 
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